[Pharmacological treatment of hereditary haemorrhagic telangiectasia]

Sonia Molinos-Castro, Sonia Molinos‐Castro, Paula María Pesqueira-Fontán, Paula M. Pesqueira-Fontán, José Antonio Díaz-Peromingo, José Antonio Díaz‐Peromingo
Revista medica de Chile · 2009 · vol. 137(5) , pp. 695–700 · doi:10.4067/s0034-98872009000500015 · PMID:19701561 · W1968442891
Review OA: diamond CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-25 ⓘ

This review discusses systemic pharmacological therapies, including antifibrinolytics and danazol, aimed at minimizing bleeding in patients with hereditary hemorrhagic telangiectasia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Hereditary hemorrhagic telangiectasia (HHT) of Rendu-Osler-Weber disease is a multi system vascular dysplasia characterized by the presence of multiple telangiectasias, mainly affecting mucosal tissue and arterial-venous connections. It commonly affects lungs, liver and central nervous system. Bleeding is the most common symptom and its treatment can be surgical or pharmacological. We herein review the systemic therapy that attempts to minimize bleeding as well as blood transfusion therapy. Blood therapy and fibrinolytic treatment especially aminocaproic acid and tranexamic acid are discussed. Danazol, hormone therapy and other less common drugs used in the treatment of HHT are also reviewed.

My notes (saved in your browser only)

MeSH descriptors

Telangiectasia, Hereditary Hemorrhagic Antifibrinolytic Agents Antifibrinolytic Agents Blood Transfusion Hormones Hormones Humans Telangiectasia, Hereditary Hemorrhagic Tranexamic Acid Tranexamic Acid

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (45)

Source provenance

openalex
last seen: 2026-05-14T05:56:02.807635+00:00
pubmed
last seen: 2026-10-08T21:06:50.232585+00:00
License: CC0 · commercial use OK